The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis
Status:
Terminated
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Emotionally labile, depressed participants with multiple sclerosis treated with escitalopram
will have a greater reduction in emotional lability scores and in their psychological
distress scores than those who are randomized to receive placebo.